The German biotechnology sector has developed remarkably in recent years. Despite global challenges, the sector is robust and growth-oriented.
In 2023, there were 798 biotechnology companies in Germany, 22 more than in the previous year. These companies employed a total of 38,120 people, which corresponds to an increase of 10.8%. The industrial biotechnology sector is particularly noteworthy with an increase in employment of 19.2 %. Medical biotechnology also remains a central pillar of the sector with 397 companies (49.7% of the sector) and over 21,200 employees.
Financial support for biotechnology companies in Germany has developed positively. In 2024, a total of EUR 1.917 billion in funding was raised, which corresponds to an increase of 78% compared to the previous year. It is noteworthy that both private and listed companies benefited from this growth. The number of venture capital financing rounds also rose significantly to 32.
Despite these positive developments, the industry is facing major challenges, particularly in the area of recruiting specialists. A survey by BIO Deutschland revealed that around 57% of companies have difficulties recruiting specialists for research and development. Positions in technical R&D and laboratory assistance are particularly affected. To counteract this shortage, 76% of companies are calling for an improvement in STEM training and 68% see the targeted immigration of skilled workers as a possible solution.
The mood in the industry is divided. While the key financial figures and employment growth are sending out positive signals, many companies are concerned about rising energy costs and the general economic situation. Nevertheless, around 42% of companies are planning to increase their investment in research and development, which indicates continued confidence in the innovative strength of German biotechnology.
Overall, the German biotechnology industry is a dynamic and fast-growing sector, but one that requires proactive measures to overcome the shortage of skilled workers and remain competitive in the long term.
The shortage of specialists poses major challenges for the biotechnology sector. We support you in the targeted recruitment of highly qualified specialists and managers. The recruitment consultants at BESTMINDS have been successfully filling key positions in medical technology, healthcare, life sciences / pharma and IT / media for over 15 years. With experience, discretion and a strong network, we will find the talent that will take your company forward. Contact us for a non-binding initial consultation - we will help you to strategically expand your team.
Sources: BIO Deutschland, BIO Deutschland, Presseportal, transkript
